Globally interfering with VMN function (e.g., by deleting VMN vGLUT2, thereby blocking glutamatergic signaling by VMN neurons) mediates effects opposite to those of VMN activation, impairing glucagon secretion, glycogenolysis, and hepatic transcriptional responses to hypoglycemia and during fasting26. This evidence concerns the gene GCG and Hypoglycemia.